179 related articles for article (PubMed ID: 15781326)
1. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
Jani M; Tordai H; Trexler M; Bányai L; Patthy L
Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
Yamamoto M; Tsujishita H; Hori N; Ohishi Y; Inoue S; Ikeda S; Okada Y
J Med Chem; 1998 Apr; 41(8):1209-17. PubMed ID: 9548812
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
[TBL] [Abstract][Full Text] [Related]
4. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
[TBL] [Abstract][Full Text] [Related]
5. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
Esser CK; Bugianesi RL; Caldwell CG; Chapman KT; Durette PL; Girotra NN; Kopka IE; Lanza TJ; Levorse DA; MacCoss M; Owens KA; Ponpipom MM; Simeone JP; Harrison RK; Niedzwiecki L; Becker JW; Marcy AI; Axel MG; Christen AJ; McDonnell J; Moore VL; Olszewski JM; Saphos C; Visco DM; Hagmann WK
J Med Chem; 1997 Mar; 40(6):1026-40. PubMed ID: 9083493
[TBL] [Abstract][Full Text] [Related]
7. Structure of recombinant mouse collagenase-3 (MMP-13).
Botos I; Meyer E; Swanson SM; Lemaître V; Eeckhout Y; Meyer EF
J Mol Biol; 1999 Oct; 292(4):837-44. PubMed ID: 10525409
[TBL] [Abstract][Full Text] [Related]
8. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.
Pavlovsky AG; Williams MG; Ye QZ; Ortwine DF; Purchase CF; White AD; Dhanaraj V; Roth BD; Johnson LL; Hupe D; Humblet C; Blundell TL
Protein Sci; 1999 Jul; 8(7):1455-62. PubMed ID: 10422833
[TBL] [Abstract][Full Text] [Related]
9. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
Bini A; Itoh Y; Kudryk BJ; Nagase H
Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-Rüth FX; Maskos K; Betz M; Bergner A; Huber R; Suzuki K; Yoshida N; Nagase H; Brew K; Bourenkov GP; Bartunik H; Bode W
Nature; 1997 Sep; 389(6646):77-81. PubMed ID: 9288970
[TBL] [Abstract][Full Text] [Related]
11. Tumor targeting with a selective gelatinase inhibitor.
Koivunen E; Arap W; Valtanen H; Rainisalo A; Medina OP; Heikkilä P; Kantor C; Gahmberg CG; Salo T; Konttinen YT; Sorsa T; Ruoslahti E; Pasqualini R
Nat Biotechnol; 1999 Aug; 17(8):768-74. PubMed ID: 10429241
[TBL] [Abstract][Full Text] [Related]
12. Comparison of native matrix metalloproteinases and their recombinant catalytic domains using a novel radiometric assay.
Brownell J; Earley W; Kunec E; Morgan BA; Olyslager B; Wahl RC; Houck DR
Arch Biochem Biophys; 1994 Oct; 314(1):120-5. PubMed ID: 7944383
[TBL] [Abstract][Full Text] [Related]
13. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
Becker JW; Marcy AI; Rokosz LL; Axel MG; Burbaum JJ; Fitzgerald PM; Cameron PM; Esser CK; Hagmann WK; Hermes JD
Protein Sci; 1995 Oct; 4(10):1966-76. PubMed ID: 8535233
[TBL] [Abstract][Full Text] [Related]
14. Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors.
Kannan R; Ruff M; Kochins JG; Manly SP; Stoll I; El Fahime M; Noël A; Foidart JM; Rio MC; Dive V; Basset P
Protein Expr Purif; 1999 Jun; 16(1):76-83. PubMed ID: 10336863
[TBL] [Abstract][Full Text] [Related]
15. Display of active subtilisin 309 on phage: analysis of parameters influencing the selection of subtilisin variants with changed substrate specificity from libraries using phosphonylating inhibitors.
Legendre D; Laraki N; Gräslund T; Bjørnvad ME; Bouchet M; Nygren PA; Borchert TV; Fastrez J
J Mol Biol; 2000 Feb; 296(1):87-102. PubMed ID: 10656819
[TBL] [Abstract][Full Text] [Related]
16. Binding preferences of hydroxamate inhibitors of the matrix metalloproteinase human fibroblast collagenase.
Toba S; Damodaran KV; Merz KM
J Med Chem; 1999 Apr; 42(7):1225-34. PubMed ID: 10197966
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-alpha processing.
Yamamoto M; Hirayama R; Naruse K; Yoshino K; Shimada A; Inoue S; Kayagaki N; Yagita H; Okumura K; Ikeda S
Drug Des Discov; 1999 Aug; 16(2):119-30. PubMed ID: 10533808
[TBL] [Abstract][Full Text] [Related]
18. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.
Tamura Y; Watanabe F; Nakatani T; Yasui K; Fuji M; Komurasaki T; Tsuzuki H; Maekawa R; Yoshioka T; Kawada K; Sugita K; Ohtani M
J Med Chem; 1998 Feb; 41(4):640-9. PubMed ID: 9484512
[TBL] [Abstract][Full Text] [Related]
19. The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B.
O'Farrell TJ; Pourmotabbed T
Arch Biochem Biophys; 1998 Jun; 354(1):24-30. PubMed ID: 9633594
[TBL] [Abstract][Full Text] [Related]
20. Identification of substrate sequences for membrane type-1 matrix metalloproteinase using bacteriophage peptide display library.
Ohkubo S; Miyadera K; Sugimoto Y; Matsuo K; Wierzba K; Yamada Y
Biochem Biophys Res Commun; 1999 Dec; 266(2):308-13. PubMed ID: 10600499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]